Equity and Ethical Considerations of Expanded Access Programs

Time: 2:15 pm
day: Day Two


• Defining what a serious condition is
• Analyzing the availability of the information from patient to the physician
• Discussing drug allocation (factors supporting country selection and number of patients in each country)
• Understanding patient selection
• Factoring in ethical considerations when ending a program